Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
136.44
-0.21 (-0.15%)
At close: Mar 28, 2025, 4:00 PM
136.84
+0.40 (0.29%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Cardinal Health Revenue
Cardinal Health had revenue of $55.26B in the quarter ending December 31, 2024, a decrease of -3.79%. This brings the company's revenue in the last twelve months to $222.28B, up 2.91% year-over-year. In the fiscal year ending June 30, 2024, Cardinal Health had annual revenue of $226.83B with 10.66% growth.
Revenue (ttm)
$222.28B
Revenue Growth
+2.91%
P/S Ratio
0.15
Revenue / Employee
$4,545,521
Employees
48,900
Market Cap
32.96B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 226.83B | 21.85B | 10.66% |
Jun 30, 2023 | 204.98B | 23.65B | 13.04% |
Jun 30, 2022 | 181.33B | 18.86B | 11.61% |
Jun 30, 2021 | 162.47B | 9.55B | 6.24% |
Jun 30, 2020 | 152.92B | 7.39B | 5.08% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
CAH News
- 3 days ago - Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2025 on May 1 - PRNewsWire
- 16 days ago - Cardinal Health, Inc. (CAH) Leerink's 2025 Global Healthcare Conference (Transcript) - Seeking Alpha
- 18 days ago - Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors - PRNewsWire
- 23 days ago - The Dividend Aristocrats Ranked By Quality Scores: March 2025 - Seeking Alpha
- 7 weeks ago - Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings - Benzinga
- 7 weeks ago - Cardinal Health Board of Directors Approves Quarterly Dividend - PRNewsWire
- 2 months ago - Cardinal Health, Inc. (CAH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Cardinal Health lifts 2025 profit forecast on specialty drugs demand - Reuters